Differential time courses of exogenous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite MPP+ in the rat striatum and nucleus accumbens measured using in vivo voltammetry

[1]  O. Hikosaka,et al.  Duration of catalepsy correlates with increased intrastriatal sulpiride. , 1997, European journal of pharmacology.

[2]  G. Gerhardt,et al.  In Vivo Assessment of Dopamine Uptake in Rat Medial Prefrontal Cortex: Comparison with Dorsal Striatum and Nucleus Accumbens , 1995, Journal of neurochemistry.

[3]  T. Maeda,et al.  Monoamine oxidase: Distribution in the cat brain studied by enzyme- and immunohistochemistry: Recent progress , 1994, Progress in Neurobiology.

[4]  G. Gerhardt,et al.  Clearance of Exogenous Dopamine in Rat Dorsal Striatum and Nucleus Accumbens: Role of Metabolism and Effects of Locally Applied Uptake Inhibitors , 1993, Journal of neurochemistry.

[5]  T. Nakazato,et al.  A triangular conditioning voltage wave does not influence spontaneous neuronal activity in the rat striatum , 1993, Journal of Neuroscience Methods.

[6]  C. Marsden,et al.  New insights into the cause of Parkinson's disease , 1992, Neurology.

[7]  T. Nakazato,et al.  Decarboxylation of Exogenous l‐3,4‐Dihydroxyphenylalanine in Rat Striatum as Studied by In Vivo Voltammetry , 1992, Journal of neurochemistry.

[8]  S. O'dell,et al.  Dopamine high-affinity transport site topography in rat brain: Major differences between dorsal and ventral striatum , 1990, Neuroscience.

[9]  T. Archer,et al.  Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease , 1990, Brain Research.

[10]  H. Fibiger,et al.  Intracarotid 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Administration: Biochemical and Behavioral Observations in a Primate Model of Hemiparkinsonism , 1990, Journal of neurochemistry.

[11]  T. Nakazato,et al.  In Vivo Voltammetric Study of 6‐Hydroxydopamine‐Induced Neuronal Degradation , 1988, Journal of neurochemistry.

[12]  Jonathan A. Stamford,et al.  Diffusion and uptake of dopamine in rat caudate and nucleus accumbens compared using fast cyclic voltammetry , 1988, Brain Research.

[13]  K. Kiuchi,et al.  Effects of Systemic Administration of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine to Mice on Tyrosine Hydroxylase, l‐3,4‐Dihydroxyphenylalanine Decarboxylase, Dopamine β‐Hydroxylase, and Monoamine Oxidase Activities in the Striatum and Hypothalamus , 1988, Journal of neurochemistry.

[14]  A. Lajtha,et al.  Kinetics of [3H]MPP+ uptake in dopaminergic neurons of mouse: regional effects of MPTP neurotoxicity. , 1986, European Journal of Pharmacology.

[15]  B. Westerink,et al.  Brain dialysis in conscious rats reveals an instantaneous massive release of striatal dopamine in response to MPP+. , 1986, European journal of pharmacology.

[16]  R. Duvoisin,et al.  Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: Implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity , 1985, Neuroscience Letters.

[17]  E. Melamed,et al.  Mesolimbic dopaminergic neurons are not spared by MPTP neurotoxicity in mice. , 1985, European journal of pharmacology.

[18]  K. Chiba,et al.  Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes. , 1985, Biochemical and biophysical research communications.

[19]  S. Snyder,et al.  Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP. , 1984, European journal of pharmacology.

[20]  R. Duvoisin,et al.  Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors , 1984, Nature.

[21]  J. Langston,et al.  Pargyline prevents MPTP-induced parkinsonism in primates. , 1984, Science.

[22]  K. Chiba,et al.  Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. , 1984, Biochemical and biophysical research communications.

[23]  D. Jacobowitz,et al.  A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.

[25]  X. Breakefield,et al.  Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons. , 1982, Proceedings of the National Academy of Sciences of the United States of America.